FDA D.I.S.C.O. Burst Edition: FDA approval of Orencia (abatacept) for prophylaxis of acute graft versus host disease
0:00
5:29
Listen to a soundcast of the December 15, 2021 FDA approval of Orencia (abatacept) for prophylaxis of acute graft versus host disease.
Flere episoder fra "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Gå ikke glip af nogen episoder af “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” - abonnér på podcasten med gratisapp GetPodcast.